Table 1.
Description of sample
| Characteristic | N (%) or Median (IQR)* |
|---|---|
| Demographic | |
| Age, years (range: 26-66) | 44 (38-48) |
| Male gender | 84 (65.6%) |
| Race: | |
| African American | 84 (65.6%) |
| Caucasian | 39 (30.5%) |
| Other | 5 (3.9%) |
| Years of schooling (range: 4-20) | 12 (12-14) |
| Employed part/full time | 42 (32.8%) |
| Monthly income, $ (range: 0-6000) | 685 (501-1300) |
| Clinical | |
| Years since HIV diagnosis (range: 0-25) | 10 (6-15) |
| On any antiretroviral therapy | 105 (82.0%) |
| CD4 count, cells/mm3 (range: 29-1755) | 457 (268-670) |
| HIV RNA viral load <400 copies/mL | 87 (68.0%) |
| Fatigue course | |
| Fatigued at baseline | 111 (88.1%) |
| Experienced remission of fatigue during follow-up** | 11 (10.7%) |
*
IQR interquartile range (25th–75th percentile)
**
Of 103 participants fatigued at baseline and with at least one follow-up visit.
BLD: Below the limit of detection (400 copies/mL)